文献速递创伤与烧伤复苏、休克与脓毒症

量化全血对需急诊剖腹探查创伤患者死亡率的获益

Quantifying the benefit of whole blood on mortality in trauma patients requiring emergent laparotomy.
PubMed 文献 · J Trauma Acute Care Surg · 2024-05-01
一句话结论需急诊剖腹探查的严重创伤患者,初始复苏中以全血为主(≥50%)与4小时和24小时死亡率降低相关,但证据等级为Level IV。

本研究为一级创伤中心2019—2022年的回顾性分析,纳入需急诊剖腹探查且在首小时内接受≥3单位含红细胞制品(全血或浓缩红细胞)的严重创伤患者266例(男性81%,平均年龄36岁,穿透伤61%,平均损伤严重度评分30)。按初始复苏中全血占比分为高比例组(≥50%全血)与低比例组(<50%全血),采用多水平贝叶斯回归分析计算后验概率与风险比。高比例组4小时死亡率11%、24小时死亡率14%,较低比例组降低死亡率的概率均为99%(4小时RR 0.12,95%可信区间0.02-0.53;24小时RR 0.22,95%可信区间0.08-0.65),全血为主策略使死亡风险相对降低至少50%的概率分别为94%和88%。作者认为全血为主的复苏可能改善早期死亡率,并建议开展前瞻性随机试验。

要点

  • 需急诊剖腹探查且首小时内接受≥3单位含红细胞制品的严重创伤患者,初始复苏全血占比≥50%较高比例组4小时死亡率11%、24小时死亡率14%,较低比例组降低死亡率的概率均为99%。
  • 全血为主复苏与4小时死亡率降低相关(RR 0.12,95%可信区间0.02-0.53),与24小时死亡率降低相关(RR 0.22,95%可信区间0.08-0.65)。
  • 全血为主策略使4小时与24小时死亡风险相对降低至少50%的概率分别为94%和88%。
  • 本研究为单中心回顾性分析,证据等级为Level IV,作者建议开展前瞻性随机试验。

适用人群与场景

  • 需急诊剖腹探查的严重创伤患者,且首小时内接受≥3单位含红细胞制品(全血或浓缩红细胞)。
  • 来自ACS一级创伤中心,2019—2022年,男性81%,平均年龄36岁,穿透伤61%,平均损伤严重度评分30。

诊断标准与关键阈值

  • 按初始复苏中全血占含红细胞制品的比例分组:高比例组≥50%全血,低比例组<50%全血。

研究设计与关键结果

  • 回顾性分析266例需急诊剖腹探查的严重创伤患者,比较高比例全血组(≥50%全血)与低比例组(<50%全血)的早期死亡率。
  • 总体死亡率4小时为11%、24小时为14%。
  • 高比例组较低比例组降低死亡率的概率:4小时99%(RR 0.12,95%可信区间0.02-0.53),24小时99%(RR 0.22,95%可信区间0.08-0.65)。
  • 全血为主策略使死亡风险相对降低至少50%的概率:4小时94%,24小时88%。

证据类型、等级与局限

  • 证据类型:回顾性分析;证据等级:Level IV(治疗/照护管理)。
  • 局限:单中心回顾性分析;作者建议开展前瞻性随机试验。

对床旁实践的改变

  • 作者认为,初始复苏中以全血为主可能改善需急诊剖腹探查严重创伤患者的早期死亡率。
  • 作者建议开展前瞻性随机试验以验证该关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Whole blood (WB) transfusions in trauma represent an increasingly utilized resuscitation strategy in trauma patients. Previous reports suggest a probable mortality benefit with incorporating WB into massive transfusion protocols. However, questions surrounding optimal WB practices persist. We sought to assess the association between the proportion of WB transfused during the initial resuscitative period and its impact on early mortality outcomes for traumatically injured patients.

METHODS: We performed a retrospective analysis of severely injured patients requiring emergent laparotomy and ≥3 units of red blood cell containing products (WB or packed red blood cells) within the first hour from an ACS Level I Trauma Center (2019-2022). Patients were evaluated based on the proportion of WB they received compared with packed red blood cells during their initial resuscitation (high ratio cohort ≥50% WB vs. low ratio cohort <50% WB). Multilevel Bayesian regression analyses were performed to calculate the posterior probabilities and risk ratios (RR) associated with a WB predominant resuscitation for early mortality outcomes.

RESULTS: Two hundred sixty-six patients were analyzed (81% male; mean age, 36 years; 61% penetrating injury; mean Injury Severity Score, 30). The mortality was 11% at 4 hours and 14% at 24 hours. The high ratio cohort demonstrated a 99% (RR, 0.12; 95% credible interval, 0.02-0.53) and 99% (RR, 0.22; 95% credible interval, 0.08-0.65) probability of decreased mortality at 4 hours and 24 hours, respectively, compared the low ratio cohort. There was a 94% and 88% probability of at least a 50% mortality relative risk reduction associated with the WB predominate strategy at 4 hours and 24 hours, respectively.

CONCLUSION: Preferential transfusion of WB during the initial resuscitation demonstrated a 99% probability of being superior to component predominant resuscitations with regards to 4-hour and 24-hour mortality suggesting that WB predominant resuscitations may be superior for improving early mortality. Prospective, randomized trials should be sought.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Lammers D, Betzold R, McClellan J, et al. Quantifying the benefit of whole blood on mortality in trauma patients requiring emergent laparotomy. J Trauma Acute Care Surg. 2024. PMID: 38689383. doi:10.1097/TA.0000000000004382

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。